Elicio Therapeutics, Inc. Quarterly Return On Equity in % from Q4 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Elicio Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q2 2024.
  • Elicio Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was -555 %, a 1439% decline year-over-year.
  • Elicio Therapeutics, Inc. annual Return On Equity for 2023 was 228 %, a 644% increase from 2022.
  • Elicio Therapeutics, Inc. annual Return On Equity for 2022 was 30.7 %.
  • Elicio Therapeutics, Inc. annual Return On Equity for 2021 was -137 %, a 200% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -555 -596 -1439% Apr 1, 2024 Jun 30, 2024
Q1 2024 -294 -323 -1098% Jan 1, 2024 Mar 31, 2024
Q4 2023 228 +198 +644% Oct 1, 2023 Dec 31, 2023
Q3 2023 75.1 +67.3 +858% Jul 1, 2023 Sep 30, 2023
Q2 2023 41.4 +7.73 +22.9% Apr 1, 2023 Jun 30, 2023
Q1 2023 29.5 -670 -95.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 30.7 +167 Oct 1, 2022 Dec 31, 2022
Q3 2022 7.84 +282 Jul 1, 2022 Sep 30, 2022
Q2 2022 33.7 +2.54K Apr 1, 2022 Jun 30, 2022
Q1 2022 699 +324 +86.2% Jan 1, 2022 Mar 31, 2022
Q4 2021 -137 -274 -200% Oct 1, 2021 Dec 31, 2021
Q3 2021 -274 Jul 1, 2021 Sep 30, 2021
Q2 2021 -2.51K Apr 1, 2021 Jun 30, 2021
Q1 2021 376 Jan 1, 2021 Mar 31, 2021
Q4 2020 137 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.